• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:挪威首例免疫功能低下患者脑膜炎病例。

Case report: First case of meningitis in an immunocompromised patient in Norway.

作者信息

Schwartz Thomas, Hoornstra Dieuwertje, Øie Erik, Hovius Joppe, Quarsten Hanne

机构信息

Department of Internal Medicine, Diakonhjemmet Hospital, Oslo, Norway.

Oslo New University College, Oslo, Norway.

出版信息

IDCases. 2023 Jul 31;33:e01867. doi: 10.1016/j.idcr.2023.e01867. eCollection 2023.

DOI:10.1016/j.idcr.2023.e01867
PMID:37577049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10412827/
Abstract

BACKGROUND

Tick-borne disease caused by (BMD) usually manifest as a febrile illness in humans. Complications include relapsing fever and in rare occasions involvement of the central nervous system. Only a few cases of meningoencephalitis have been described, mostly in immunosuppressed patients.

CASE PRESENTATION

A 70-year-old female receiving immunosuppressive rituximab therapy presented with frontal headache, dizziness, nausea, vomiting and chills. Clinical laboratory blood analyses were normal. Cerebrospinal fluid (CSF) was translucent and analysis showed increased leucocyte count (187 10/L) and elevated level of protein (1056 mg/L). Empiric antibiotic treatment was initiated. The patient showed an early symptomatic relief and 24 h after admission she was discharged from the hospital and antibiotic treatment was discontinued. Two weeks after hospitalisation the specific PCR turned out positive in both CSF and serum. At the time, the patient was recovered with mild residual headache. She was treated with high dose doxycycline and her subtle symptoms disappeared.

CONCLUSIONS

To our knowledge, we present the first patient with BMD-associated meningitis in Norway, one of eight cases reported worldwide. The patient had mild symptoms and received an early diagnosis. A more severe progression or relapse of disease may have been prevented by antibiotic treatment. BMD should be considered as causes of aseptic meningitis, especially in immunosuppressed patients living in endemic areas.

摘要

背景

由[病原体名称未给出]引起的蜱传疾病(BMD)在人类中通常表现为发热性疾病。并发症包括回归热,在极少数情况下会累及中枢神经系统。仅描述了少数几例脑膜脑炎病例,大多发生在免疫抑制患者中。

病例报告

一名70岁接受免疫抑制利妥昔单抗治疗的女性出现前额头痛、头晕、恶心、呕吐和寒战。临床实验室血液分析正常。脑脊液(CSF)半透明,分析显示白细胞计数增加(187×10⁶/L)和蛋白质水平升高(1056mg/L)。开始经验性抗生素治疗。患者症状早期缓解,入院24小时后出院,抗生素治疗停止。住院两周后,脑脊液和血清中的[病原体名称未给出]特异性PCR均呈阳性。此时,患者已康复,仅遗留轻度头痛。她接受了高剂量强力霉素治疗,轻微症状消失。

结论

据我们所知,我们报告了挪威首例与BMD相关的脑膜炎患者,这是全球报告的八例病例之一。该患者症状轻微且得到了早期诊断。抗生素治疗可能预防了疾病更严重的进展或复发。BMD应被视为无菌性脑膜炎的病因,尤其是在流行地区的免疫抑制患者中。

相似文献

1
Case report: First case of meningitis in an immunocompromised patient in Norway.病例报告:挪威首例免疫功能低下患者脑膜炎病例。
IDCases. 2023 Jul 31;33:e01867. doi: 10.1016/j.idcr.2023.e01867. eCollection 2023.
2
Borrelia miyamotoi infection in nature and in humans.日本疏螺旋体在自然界及人类中的感染情况。
Clin Microbiol Infect. 2015 Jul;21(7):631-9. doi: 10.1016/j.cmi.2015.02.006. Epub 2015 Feb 18.
3
Assessment of Borrelia miyamotoi in febrile patients and ticks in Alsace, an endemic area for Lyme borreliosis in France.评估发热患者和法国莱姆病流行地区阿尔萨斯的蜱中的伯氏疏螺旋体。
Parasit Vectors. 2020 Apr 17;13(1):199. doi: 10.1186/s13071-020-04071-9.
4
-An Emerging Human Tick-Borne Pathogen in Europe.欧洲一种新出现的蜱传人类病原体。
Microorganisms. 2021 Jan 12;9(1):154. doi: 10.3390/microorganisms9010154.
5
Are other tick-borne infections overlooked in patients investigated for Lyme neuroborreliosis? A large retrospective study from South-eastern Sweden.在调查莱姆神经Borreliosis 的患者时,是否忽略了其他蜱传感染?来自瑞典东南部的一项大型回顾性研究。
Ticks Tick Borne Dis. 2021 Sep;12(5):101759. doi: 10.1016/j.ttbdis.2021.101759. Epub 2021 Jun 4.
6
Borrelia miyamotoi Disease in the Northeastern United States: A Case Series.美国东北部的米亚马托氏菌病:病例系列。
Ann Intern Med. 2015 Jul 21;163(2):91-8. doi: 10.7326/M15-0333.
7
First detection of Borrelia miyamotoi infections in ticks and humans from the northeast of Inner Mongolia, China.首次在中国内蒙古东北部的蜱和人类中检测到伯氏疏螺旋体感染。
Acta Trop. 2021 May;217:105857. doi: 10.1016/j.actatropica.2021.105857. Epub 2021 Feb 11.
8
Evaluation of a serological test for the diagnosis of Borrelia miyamotoi disease in Europe.欧洲用于诊断宫本疏螺旋体病的血清学检测评估。
J Microbiol Methods. 2017 May;136:11-16. doi: 10.1016/j.mimet.2017.02.013. Epub 2017 Mar 1.
9
Borrelia miyamotoi - new etiologic agent of neuroborreliosis?宫本疏螺旋体——神经莱姆病的新病原体?
Przegl Epidemiol. 2017;71(4):531-538.
10
[Relapsing (recurrent) disease caused by Borrelia miyamotoi].由宫本疏螺旋体引起的复发性疾病
Ter Arkh. 2015;87(11):18-25. doi: 10.17116/terarkh2015871118-25.

本文引用的文献

1
Development and Validation of a Protein Array for Detection of Antibodies against the Tick-Borne Pathogen Borrelia miyamotoi.用于检测蜱传病原体伯氏疏螺旋体抗体的蛋白质芯片的开发和验证。
Microbiol Spectr. 2022 Dec 21;10(6):e0203622. doi: 10.1128/spectrum.02036-22. Epub 2022 Oct 31.
2
Prevalence and clinical manifestation of Borrelia miyamotoi in Ixodes ticks and humans in the northern hemisphere: a systematic review and meta-analysis.在北半球,伯氏疏螺旋体在硬蜱和人类中的流行情况和临床表现:系统评价和荟萃分析。
Lancet Microbe. 2022 Oct;3(10):e772-e786. doi: 10.1016/S2666-5247(22)00157-4. Epub 2022 Sep 13.
3
Meningoencephalitis in an Immunocompetent Patient.免疫功能正常患者的脑膜脑炎
Open Forum Infect Dis. 2022 Jun 13;9(7):ofac295. doi: 10.1093/ofid/ofac295. eCollection 2022 Jul.
4
Spatial patterns of pathogen prevalence in questing Ixodes ricinus nymphs in southern Scandinavia, 2016.2016 年在南斯堪的纳维亚地区,寻血蜱若虫中病原体流行率的空间格局。
Sci Rep. 2020 Nov 9;10(1):19376. doi: 10.1038/s41598-020-76334-5.
5
Case 32-2020: A 63-Year-Old Man with Confusion, Fatigue, and Garbled Speech.病例32 - 2020:一名63岁男性,伴有意识模糊、疲劳和言语不清。
N Engl J Med. 2020 Oct 15;383(16):1578-1586. doi: 10.1056/NEJMcpc2004996.
6
Tick-borne Pathogens Detected in the Blood of Immunosuppressed Norwegian Patients Living in a Tick-endemic Area.蜱传病原体在生活在蜱传疾病流行地区的免疫抑制挪威患者血液中被检测到。
Clin Infect Dis. 2021 Oct 5;73(7):e2364-e2371. doi: 10.1093/cid/ciaa971.
7
Draft Whole-Genome Sequences of Two Western European Borrelia miyamotoi Isolates.两株西欧宫本疏螺旋体分离株的全基因组序列草图
Microbiol Resour Announc. 2019 Dec 12;8(50):e01314-19. doi: 10.1128/MRA.01314-19.
8
Two Cases of Borrelia miyamotoi Meningitis, Sweden, 2018.两例伯氏疏螺旋体脑膜炎,瑞典,2018 年。
Emerg Infect Dis. 2019 Oct;25(10):1965-1968. doi: 10.3201/eid2510.190416.
9
Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.伯氏疏螺旋体感染导致小鼠和人类对 C6 肽产生交叉反应性抗体。
Clin Microbiol Infect. 2020 Apr;26(4):513.e1-513.e6. doi: 10.1016/j.cmi.2019.07.026. Epub 2019 Aug 9.
10
A new on the block: - a human health risk?新兴污染物:— 对人类健康的风险?
Euro Surveill. 2019 May;24(18). doi: 10.2807/1560-7917.ES.2019.24.18.1800170.